IDH1 and acute myeloid leukemia: In 2009, recurrent mutations in genes of two crucial metabolic enzymes, cytosolic isocitrate dehydrogenase (IDH)1 and mitochondrial IDH2, were observed in about 20% of AML patients [135–138], reinforcing the importance of furthering metabolic investigations in AML.